Virtual Auditorium Event: HOW WILL THE STRAINED SWITZERLAND–EU RELATIONS AFFECT SWISS LIFE SCIENCE VENTURES?
We warmly welcome you to our first virtual auditorium event. The Technologiepark Basel and the Swiss Biotech Association, in cooperation with Muresan | Legal, invite you to this online event about:
HOW WILL THE STRAINED SWITZERLAND – EU RELATIONS AFFECT SWISS LIFE SCIENCE VENTURES?
Relations between Switzerland and the European Union have considerably cooled during the past months. The first to suffer individual adverse consequences in terms of market access is the Medtech sector. However, other life science ventures (Biotech, pharma) may also be affected in the near future. The event will provide an overview of what to watch out for.
The webinar will include a Q&A part with the opportunity to discuss individual situations and questions. Please submit your questions beforehand here to allow the speakers to prepare.
When: 14.01.2021, 13:00 - 14:15
Participation is free, however, registration is required before April 29, 2021. You will receive the link to the event after your registration has been confirmed. Follow this link to confirm your participation.
We look forward to welcoming you to our event.
Ginkgo Bioworks Signs Definitive Agreement to Acquire FGen A...
Cellestia Biotech receives Orphan Drug Designation from the ...
Anaveon to raise CHF 110 million in oversubscribed Series B ...
Kinarus receives 7 Million CHF Grant from the Swiss Federal ...